loading
前日終値:
$429.18
開ける:
$427.07
24時間の取引高:
477.24K
Relative Volume:
1.35
時価総額:
$9.50B
収益:
-
当期純損益:
$-518.67M
株価収益率:
-17.07
EPS:
-25.12
ネットキャッシュフロー:
$-438.32M
1週間 パフォーマンス:
+3.10%
1か月 パフォーマンス:
-3.22%
6か月 パフォーマンス:
+25.83%
1年 パフォーマンス:
+96.90%
1日の値動き範囲:
Value
$393.61
$434.48
1週間の範囲:
Value
$393.61
$436.84
52週間の値動き範囲:
Value
$213.71
$463.62

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
名前
Madrigal Pharmaceuticals Inc
Name
セクター
Healthcare (1143)
Name
電話
404-380-9263
Name
住所
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
職員
528
Name
Twitter
@MadrigalPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MDGL's Discussions on Twitter

MDGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
427.86 9.57B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.39 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
653.93 69.37B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
479.74 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
830.42 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.09 34.94B 398.11M -1.03B -868.57M -5.7032

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-15 開始されました Truist Buy
2025-09-04 再開されました H.C. Wainwright Buy
2025-02-28 アップグレード B. Riley Securities Neutral → Buy
2025-02-27 繰り返されました H.C. Wainwright Buy
2024-06-28 開始されました Cantor Fitzgerald Neutral
2024-06-11 開始されました Wolfe Research Outperform
2024-04-22 開始されました BofA Securities Underperform
2024-03-15 アップグレード B. Riley Securities Sell → Neutral
2024-03-06 開始されました Citigroup Buy
2024-02-26 ダウングレード B. Riley Securities Neutral → Sell
2022-12-20 繰り返されました Oppenheimer Outperform
2022-12-19 繰り返されました H.C. Wainwright Buy
2022-12-19 繰り返されました Piper Sandler Overweight
2022-12-19 アップグレード Raymond James Underperform → Mkt Perform
2022-07-08 ダウングレード B. Riley Securities Buy → Neutral
2021-10-07 開始されました Jefferies Buy
2021-08-06 アップグレード BMO Capital Markets Market Perform → Outperform
2021-05-20 再開されました Goldman Buy
2020-11-24 再開されました Evercore ISI Outperform
2020-11-06 繰り返されました H.C. Wainwright Buy
2020-07-31 開始されました Piper Sandler Overweight
2020-06-05 開始されました BMO Capital Markets Market Perform
2020-05-05 開始されました Chardan Capital Markets Buy
2020-01-30 開始されました Canaccord Genuity Buy
2020-01-09 アップグレード UBS Neutral → Buy
2019-11-07 繰り返されました H.C. Wainwright Buy
2019-06-25 開始されました Stifel Hold
2019-06-10 アップグレード B. Riley FBR Neutral → Buy
2019-02-28 繰り返されました H.C. Wainwright Buy
2019-02-22 開始されました SVB Leerink Outperform
2019-01-23 開始されました UBS Neutral
2018-12-14 開始されました Wolfe Research Outperform
2018-12-12 開始されました B. Riley FBR Neutral
2018-11-19 ダウングレード Raymond James Mkt Perform → Underperform
2018-11-16 アップグレード Evercore ISI In-line → Outperform
2018-09-04 開始されました Citigroup Buy
2018-08-06 ダウングレード Goldman Buy → Neutral
2018-06-28 開始されました Raymond James Mkt Perform
すべてを表示

Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース

pulisher
07:53 AM

How Madrigal Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com

07:53 AM
pulisher
04:53 AM

How to escape a deep drawdown in Madrigal Pharmaceuticals Inc.Weekly Gains Report & Community Verified Trade Alerts - newser.com

04:53 AM
pulisher
02:31 AM

Is Madrigal Pharmaceuticals Inc. trending in predictive chart modelsEarnings Trend Report & Technical Buy Zone Confirmation - newser.com

02:31 AM
pulisher
01:47 AM

Can Madrigal Pharmaceuticals Inc. stock hit record highs againPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com

01:47 AM
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025 - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (NASDAQ: MDGL) to present cirrhosis and real-world Rezdiffra data at AASLD 2025 - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep raising dividendsBond Market & Capital Efficiency Focused Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Inc. stock trendline breakdownPortfolio Value Summary & Stepwise Trade Execution Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Chart based exit strategy for Madrigal Pharmaceuticals Inc.Quarterly Investment Review & Precise Buy Zone Identification - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How forex fluctuations impact Madrigal Pharmaceuticals Inc. (YDO1) stockEarnings Trend Report & Daily Technical Stock Forecast Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Statistical indicators supporting Madrigal Pharmaceuticals Inc.’s strengthTrade Signal Summary & Expert Approved Momentum Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How to integrate Madrigal Pharmaceuticals Inc. into portfolio analysis toolsMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock profit from AI boom2025 Earnings Impact & Daily Chart Pattern Signals - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is it too late to sell Madrigal Pharmaceuticals Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Madrigal Pharmaceuticals set to unveil Q3 2025 financial results on November 4 - Traders Union

Oct 27, 2025
pulisher
Oct 27, 2025

Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Is Madrigal Pharmaceuticals Inc a good long term investmentProtective Put Strategies & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Oct 26, 2025
pulisher
Oct 26, 2025

Madrigal Pharmaceuticals: Rezdiffra Commercialization Bode Well For Continued Growth MDGL - Seeking Alpha

Oct 26, 2025

Madrigal Pharmaceuticals Inc (MDGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.77
price up icon 1.06%
$90.31
price down icon 1.45%
$29.00
price down icon 0.36%
$104.98
price down icon 0.08%
biotechnology ONC
$314.22
price down icon 0.61%
$164.99
price down icon 0.18%
大文字化:     |  ボリューム (24 時間):